JPY 6870.0
(0.29%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 471 Million | 996 Million | 861 Million | 1.08 Billion | 833.35 Million | 776.49 Million |
Net Income | 697 Million | 483 Million | 303 Million | 375.17 Million | -983.4 Million | 165.03 Million |
Depreciation & Amortization | 385 Million | 430 Million | 434 Million | 452.67 Million | 478.31 Million | 443.79 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -649 Million | 33 Million | 129 Million | 282.24 Million | 1.18 Billion | 250.59 Million |
Other non-cash items | 1.6 Billion | 903 Million | 607 Million | 308.56 Million | 185.47 Million | 436.99 Million |
Investing Cash Flow | -700 Million | -178 Million | -84 Million | -73.26 Million | -152.61 Million | -2.68 Billion |
Investments in PPE | -174 Million | -178 Million | -104 Million | -73.26 Million | -152.61 Million | -2.88 Billion |
Acquisitions | - | - | - | - | - | - |
Investment purchases | -565 Million | - | -75 Million | - | - | - |
Sales/Maturities of investments | 39 Million | - | 95 Million | - | - | 190.03 Million |
Other Investing Activities | -562 Million | -42 Million | 16 Million | -1 Million | -25 Million | 14.09 Million |
Financing Cash Flow | -516 Million | -432 Million | -396 Million | -407.12 Million | -127.86 Million | -37.5 Million |
Debt repayment | -312 Million | -312 Million | -312 Million | -335.53 Million | -78.15 Million | -2.49 Million |
Dividends payments | -32 Million | -33 Million | -34 Million | -34.68 Million | -34.73 Million | -34.56 Million |
Common Stock Repurchased | -170 Million | -86 Million | -49 Million | -36.9 Million | -14.97 Million | -448 Thousand |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -2 Million | -1 Million | -1 Million | -2 Million | -1 Million | - |
Accounts receivables | -806 Million | -282 Million | 726 Million | 568.17 Million | 521.31 Million | 303.67 Million |
Accounts payables | -81 Million | 185 Million | -234 Million | 40.63 Million | -41.23 Million | -161.41 Million |
Inventory | 91 Million | 104 Million | -236 Million | -37.43 Million | 446.89 Million | 225.39 Million |
Other working capital | 147 Million | 26 Million | -127 Million | -289.12 Million | 255.62 Million | -117.07 Million |
Cash at beginning of period | 4.14 Billion | 3.76 Billion | 3.38 Billion | 2.77 Billion | 2.22 Billion | 4.16 Billion |
Cash at end of period | 3.4 Billion | 4.14 Billion | 3.76 Billion | 3.38 Billion | 2.77 Billion | 2.22 Billion |
Capital Expenditure | -174 Million | -178 Million | -104 Million | -73.26 Million | -152.61 Million | -2.88 Billion |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | -745 Million | 385 Million | 380.18 Million | 604.3 Million | 552.87 Million | -1.94 Billion |
Free Cash Flow | 297 Million | 818 Million | 757 Million | 1.01 Billion | 680.73 Million | -2.1 Billion |
Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 271 Million | 354 Million | 241 Million | 275 Million | 697 Million | 185 Million |
Depreciation & Amortization | - | - | - | - | 385 Million | - |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | - | - | -649 Million | - |
Other non-cash items | -271 Million | -354 Million | -241 Million | -275 Million | 1.6 Billion | -185 Million |
Investing Cash Flow | - | - | - | - | -700 Million | - |
Investments in PPE | - | - | - | - | -174 Million | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | -565 Million | - |
Sales/Maturities of investments | - | - | - | - | 39 Million | - |
Other Investing Activities | - | - | - | - | -562 Million | - |
Financing Cash Flow | - | - | - | - | -516 Million | - |
Debt repayment | - | - | - | - | -312 Million | - |
Dividends payments | - | - | - | - | -32 Million | - |
Common Stock Repurchased | - | - | - | - | -170 Million | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | - | - | - | -2 Million | - |
Accounts receivables | - | - | - | - | -806 Million | - |
Accounts payables | - | - | - | - | -81 Million | - |
Inventory | - | - | - | - | 91 Million | - |
Other working capital | - | - | - | - | 147 Million | - |
Cash at beginning of period | - | - | - | - | 4.14 Billion | - |
Cash at end of period | - | - | - | - | 3.4 Billion | - |
Capital Expenditure | - | - | - | - | -174 Million | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | - | - | - | - | -745 Million | - |
Free Cash Flow | - | - | - | - | 297 Million | - |
CGFEF
WAL
9552
1849
1419
LU7